Molecular Biology Enzymes and Kits & Reagents Market by Product- 2022
Market Synopsis of Global Molecular Biology Kits and
Reagents and Enzymes
The global molecular biology kits and reagents and enzymes market was valued at $4,928.3 million in 2015 and it is expected to grow at a
CAGR of 17.2% during 2016 - 2022. The molecular biology kits and reagents and
enzymes market is growing due to increasing geriatric population, increasing
prevalence of infectious diseases, and growing cases with genetic disorders. In
addition, increasing healthcare expenditure resulting in improvement in
research activities is further driving the market growth.
Read market summary report here : http://bit.ly/2Fq992t
Regional Analysis of Global Molecular Biology Kits and
Reagents and Enzymes
Geographically, North America has been globally the largest
market of molecular biology kits and reagents and enzymes, owing to the
improvement in research and development activities and increasing cases with
genetic disorders in the region. Furthermore, increase in number of
pharmaceutical and biotechnology companies are also driving the market growth
in this region.
However, the molecular biology kits and reagents and enzymes
market is expected to witness fastest growth in Asia-Pacific, with a CAGR of
17.8% during the forecast period. The high growth is attributed to increasing
awareness about molecular biology kits and reagents and enzymes and increasing
cases with molecular diagnostics in the region.
Get sample report here : http://bit.ly/2Gd7xWO
Key Players
Some of the competitors in the global molecular biology kits
& reagents and enzymes market are Thermo Fisher Scientific, Inc., Merck
KGAA, Qiagen N.V., Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd,
Becton, Dickinson and Company, Promega Corporation, New England Biolabs, Inc.,
Illumina, Inc. and Takara Bio Inc.
Contact:
P&S Market Research
347, 5th Ave. #1402
New York City, NY - 10016
Toll-Free: +1-888-778-7886 (USA/Canada)
Email: enquiry@psmarketresearch.com
Comments
Post a Comment